Platelet glycoprotein IIb/IIIa receptor blockade in coronary artery disease
<p>Abstract</p> <p>Glycoprotein IIb/IIIa inhibitors represent a new promising class of antiplatelet medications. Their use in acute coronary syndromes and for patients undergoing percutaneous coronary intervention has been the subject of a number of large controlled trials using both the intravenous...
I tiakina i:
| Ngā kaituhi matua: | , |
|---|---|
| Hōputu: | Artigo |
| Reo: | Inglês |
| I whakaputaina: |
BMC
2001-07-01
|
| Rangatū: | Current Controlled Trials in Cardiovascular Medicine |
| Ngā marau: | |
| Urunga tuihono: | http://cvm.controlled-trials.com/content/2/4/171 |
| Ngā Tūtohu: |
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!
|